Despite great progress made by scientists and physicians dedicated to cancer research, a lot of increasingly complex questions remain to be answered – to discover new ways to prevent, detect and treat cancer.
You can quickly gain answers to your questions in cancer research, if you rely on our expertise in all cancer sample types and analytes – from discovery to diagnostics. We provide Sample to Insight solutions to advance your research, accelerate your journey to insights and help to conquer cancer. Join our community and let’s do it together …
QIAGEN participates in numerous renowned international consortia, grant projects and initiatives that strive to improve global healthcare. They extend and access networks and infrastructures – and stimulate exchange between all relevant stakeholders – from science, medicine and government.
Our active role in consortia and initiatives keeps QIAGEN at the forefront of scientific findings and developments.
Cancer ID – a new way to track cancer
SPIDIA4P – better diagnosis and medical research
CBmed – biomarker identification, validation and research
EASI-Genomics – cutting-edge DNA sequencing technologies
EU-STANDS4PM – standards for in silico approaches in personalized medicine